Antifungal agents
Inventors
Balkovec, James M. • Siliphaivanh, Phieng • Bouffard, Frances A. • BOUFFARD, LEGAL REPRESENTATIVE ROLAND A., null • Peel, Michael R. • Fan, Weiming • Mamai, Ahmed • Gray, Sarah Dimick
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Novel derivatives of enfumafungin are disclosed herein, along with their, pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antifungal agents and/or inhibitors of (1,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions.
Core Innovation
The disclosed compounds are enfumafungin-derived Formula (I) and Formula (Ia) compounds, including substituted chrysene-7-carboxylic acid derivatives sharing a tetracyclic scaffold, that function as antifungal agents inhibiting (1,3)-̠-D-glucan synthase. These compounds encompass amino-acid-derived ester and acyloxy side chains, cyclic or acyclic amine groups, amide, urea, and sulfonamide substituents, as well as pharmaceutically acceptable salts and prodrugs thereof.
The subject matter further provides pharmaceutical compositions and methods for treating or preventing fungal infections across diverse infection sites and fungal pathogens, including Candida and Aspergillus species. Structural characterization includes mass spectrometric and NMR data. Because background and summary sections are omitted from the provided text, the specific unmet technical problem being solved is not explicitly described in patent.
Claims Coverage
The independent claims cover three inventive features: Formula (I) compounds, compositions containing those compounds, and methods of treating fungal infections.
Formula (I) compounds
Claim 1 covers a compound of Formula (I), or a pharmaceutically acceptable salt or prodrug thereof. The claim element defines X as O or H,H, sets out substituent choices for R1 (including hydroxy, alkoxy, cycloalkoxy, heterocyclyl, and acyloxy alternatives), R2 (selected from alkyl or heterocyclyl), and R3 (selected from hydroxymethyl, ester, and carboxy alternatives), and provides nested definitions and substitution alternatives for R4 through R11.
Compositions containing Formula (I) compounds
Claim 14 covers a composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt or prodrug thereof, together with a carrier, adjuvant, or vehicle.
Treatment of fungal infections
Claim 16 covers a method of treating a fungal infection in a patient in need thereof, comprising administering an effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt or prodrug thereof.
The independent claims cover the tetracyclic Formula (I) compound class, compositions containing these compounds alongside a carrier, adjuvant, or vehicle, and therapeutic methods administering an effective amount to treat fungal infections.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Treatment or prevention of fungal infections in a patient in need thereof using a compound of Formula (I), or a pharmaceutically acceptable salt or prodrug thereof, across diverse infection sites and fungal pathogens, including infections associated with Aspergillus, Candida, Cryptococcus, and Hormonema.
Interested in licensing this patent?